BCPEM
IDIX

Bain Capital Public Equity Management’s IDENIX PHARMACEUTICALS INC IDIX Stock Holding History

Bain Capital Public Equity Management’s Portfolio IDIX Stock Details IDIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-3,364,623
Closed -$81.1M – 66
2014
Q2 		$81.1M Sell
3,364,623
-5,639,728
-63% -$58.8M 1.96% 19
2014
Q1 		$54.3M Sell
9,004,351
-4,111,507
-31% -$28.7M 1.45% 27
2013
Q4 		$78.4M Buy
13,115,858
+450,908
+4% +$2.09M 2.22% 20
2013
Q3 		$65.7M Hold
12,664,950
– – 1.65% 27
2013
Q2 		$45.7M Buy
+12,664,950
New +$51.8M 1.07% 35

Bain Capital Public Equity Management's IDIX Position: Q3 2014 in Review

Bain Capital Public Equity Management sold out of IDENIX PHARMACEUTICALS INC (IDIX) in Q3 2014, closing a stake of 3,364,623 shares — an estimated $81.1M sold.

Bain Capital Public Equity Management first reported a position in IDIX in Q2 2013 and held it in 5 quarters. The position peaked at $81.1M in Q2 2014. 0 funds tracked by Wall St. Rank hold IDIX as of Q3 2014.

  • Bain Capital Public Equity Management reported no remaining IDENIX PHARMACEUTICALS INC position as of Q3 2014 after selling out during the quarter.
  • Bain Capital Public Equity Management sold 3,364,623 IDENIX PHARMACEUTICALS INC shares in Q3 2014, an estimated $81.1M.
  • Bain Capital Public Equity Management first reported a position in IDENIX PHARMACEUTICALS INC in Q2 2013 and held it in 5 quarters.
  • Bain Capital Public Equity Management's IDENIX PHARMACEUTICALS INC position peaked at $81.1M in Q2 2014.
  • 0 funds tracked by Wall St. Rank held IDENIX PHARMACEUTICALS INC as of Q3 2014.

Based on Bain Capital Public Equity Management's 13F filing for Q3 2014, filed 14 Nov 2014.